Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The Contemporary Management of Colorectal Cancer
1
x
$
30.00
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
1
x
$
0.00
Claus Rosenberg, MD: Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice
1
x
$
30.00
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 1, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Functional Assessment Staging (FAST)
1
x
$
0.00
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Cannabis Pen-Induced Psychosis in a First-Time Adolescent User
1
x
$
30.00
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder
1
x
$
30.00
Letter From the Editors: A Standing Ovation for a Change in How We Treat Patients With Cancer —Forever
1
x
$
0.00
Michael S. Clark, MD, PhD: The 5-HT1B Receptor: Behavioral Implications
1
x
$
30.00
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
1
x
$
30.00
Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report
1
x
$
30.00
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
1
x
$
30.00
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
1
x
$
0.00
Great Expectations in Stereochemistry: Focus on Antidepressants
1
x
$
0.00
New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report
1
x
$
30.00
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
1
x
$
30.00
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
1
x
$
0.00
Mechanism of Action of Antidepressants
1
x
$
30.00
Pharmacy Practice: Monitoring Chemotherapy in an Aging Population
1
x
$
0.00
Claudio A. Caamaño, PhD: Corticosteroid Receptors: A Dynamic Interplay Between Protein Folding and Homeostatic Control
1
x
$
30.00
View Cart
Checkout
Home
Store
“Claudio A. Caamaño, PhD: Corticosteroid Receptors: A Dynamic Interplay Between Protein Folding and Homeostatic Control” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Phebe Tucker, MD: Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo
$
30.00
Add to cart
Details
J. Douglas Bremner, MD: Functional Neuroanatomical Correlates of Traumatic Stress Revisited 7 Years Later, This Time with Data
$
30.00
Add to cart
Details
Graeme F. Mason, PhD: Magnetic Resonance Spectroscopy for Studies of Neurotransmission in Vivo
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
$
30.00
Add to cart
Details
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
$
30.00
Add to cart
Details
Jane P. Gagliardi, MD: Evidence-Based Mental Health Use of Anticonvulsants During Pregnancy
$
30.00
Add to cart
Details
Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
$
30.00
Add to cart
Details
Gregor E. Berger, MD, FMH Psych (CH): Incipient Neurovulnerability and Neuroprotection in Early Psychosis
$
30.00
Add to cart
Details
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Maria Dolores Escarabajal, PhD: DDTC, a Metabolite of Disulfiram, Reduces the Stimulating Effect on Ethanol’s Locomotor Activity in Mice
$
30.00
Add to cart
Details
Nunzio Pomara, MD: Therapeutic Implications of HPA Axis Abnormalities in Alzheimer’s Disease: Review and Update
$
30.00
Add to cart
Details
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
$
30.00
Add to cart
Details
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
$
30.00
Add to cart
Details
Jun-Sheng Wang, MD, PhD: Pharmacokinetics and Drug Interactions of the Sedative Hypnotics
$
30.00
Add to cart
Details
Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder
$
30.00
Add to cart
Details
Haim Einat, PhD: New Approaches to Modeling Bipolar Disorder
$
30.00
Add to cart
Details
J. Douglas Bremner, MD: Does Isotretinoin Cause Depression and Suicide?
$
30.00
Add to cart
Details
Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach
$
30.00
Add to cart
Details
Laura Cousino Klein, PhD: Smoking Abstinence Impairs Time Estimation Accuracy in Cigarette Smokers
$
30.00
Add to cart
Details
Previous
1
…
11
12
13
…
44
Next
Page load link
Go to Top
